Patents by Inventor Brendan Scott Crabb

Brendan Scott Crabb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Attenuated circovirus
    Patent number: 7442378
    Abstract: An isolated attenuated circovirus having a mutation in viral nucleic acid encoding viral protein 2 (VP2). The attenuated circovirus is particularly suitable for use in conferring immunity in an animal, particularly birds.
    Type: Grant
    Filed: June 14, 2002
    Date of Patent: October 28, 2008
    Assignee: The University of Melbourne
    Inventors: Glenn Francis Browning, Kelly Ann Tivendale, Peter Christopher Scott, Hayley Kay Brown, Brendan Scott Crabb, Michelle Alma Peters
  • Equine herpesvirus glycoproteins
    Patent number: 6544526
    Abstract: A vaccine for the selective immunization of horses against EHV4 and/or EHV1 is provided comprising at least one of (i) EHV4 virus wherein a portion of the gG gene of the EHV4 virus that elicits a type-specific response to EHV4 has been deleted and (ii) EHV1 virus wherein a portion of the gG gene of the EHV1 virus that elicits a type-specific response to EHV1 has been deleted. Antibodies which specifically bind to a epitopes of EHV4 gG or EHV1 also are provided.
    Type: Grant
    Filed: November 7, 2000
    Date of Patent: April 8, 2003
    Assignee: The University of Melbourne
    Inventors: Brendan Scott Crabb, Michael Justin Studdert
  • Equine herpesvirus glycoproteins
    Patent number: 6193983
    Abstract: A vaccine for the selective immunization of horses against EHV4 and/or EHV1 is provided comprising at least one of (i) EHV4 virus wherein a portion of the gG gene of the EHV4 virus that elicits a type-specific response to EHV4 has been deleted and (ii) EHV1 virus wherein a portion of the gG gene of the EHV1 virus that elicits a type-specific response to EHV1 has been deleted. Antibodies which specifically bind to a epitopes of EHV4 gG or EHV1 also are provided.
    Type: Grant
    Filed: March 15, 1999
    Date of Patent: February 27, 2001
    Assignee: The University of Melbourne
    Inventors: Brendan Scott Crabb, Michael Justin Studdert
  • Equine herpes virus glycoproteins
    Patent number: 5922327
    Abstract: Equine rhinopneumonitis and equine abortion are horse diseases caused by two distinct but antigenically related viruses designated as equine herpes virus 4 (EHV4) and equine herpes virus 1 (EHV1). Glycoprotein G (gG) epitopes of EHV1 and EHV4 of this invention allow for accurate, type-specific diagnosis of the infections despite extensive antigenic cross-reactivity between the two viruses.
    Type: Grant
    Filed: January 25, 1995
    Date of Patent: July 13, 1999
    Assignee: The University of Melbourne
    Inventors: Brendan Scott Crabb, Michael Justin Studdert